SRPT

Sarepta Therapeutics Inc (SRPT)

US
$ 36.433.29%

Price Chart

Key Statistics

Market Cap
$ 3.79B
P/E Ratio
0.00
Revenue (TTM)
$ 2.23B
Volume
3.98M
52W High
$ 173.25
52W Low
$ 34.10
Dividend Yield
0.00%
Beta
0.84

Technicals

50-Day MA
53.7068
200-Day MA
103.9538
52 Week High
173.25
52 Week Low
34.1

About SRPT

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalitie.

Employees
1372
Headquarters
Cambridge, MA
CEO
Mr. Douglas S. Ingram Esq.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg